References
- Sung H, Ferlay J, Rebecca L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
- Etemadi A, Safiri S, Sepanlou SG. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):42–54. doi:10.1016/S2468-1253(19)30328-0
- Yoshihara M, Sumii K, Haruma K, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol. 1998;93(7):1090–1096. doi:10.1111/j.1572-0241.1998.00335.x
- Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33:245–254. doi:10.1038/ng1089
- Pfeifer GP. Defining driver DNA methylation changes in human cancer. Int J Mol Sci. 2018;19(4):1166. doi:10.3390/ijms19041166
- Wen JF, Zheng T, Hu KF, et al. Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection. Oncotarget. 2017;8(44):77783–77793. doi:10.18632/oncotarget.20782
- Bernal C, Aguayo F, Villarroel C, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res. 2008;14(19):6264–6269. doi:10.1158/1078-0432.CCR-07-4522
- Wang H, Zheng Y, Lai J, Luo Q, Ke H, Chen Q. Methylation-sensitive melt curve analysis of the reprimo gene methylation in gastric cancer. PLoS One. 2016;11(12):e0168635. doi:10.1371/journal.pone.0168635
- Oh T, Kim N, Moon Y, et al. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. J Mol Diagn. 2013;15(4):498–507. doi:10.1016/j.jmoldx.2013.03.004
- Xu F, Yu FF, Han JY, et al. Detection of circulating tumor DNA methylation in diagnosis of colorectal cancer. Clin Transl Gastroenterol. 2021;12(8):e00386. doi:10.14309/ctg.0000000000000386
- Wang JW, Lu C, Chen JY, et al. Expression of Syndecan-2 in gastric adenocarcinoma and its effect on tumorigenesis in vitro. Transl Cancer Res. 2017;6:658–66.
- Kwon OH, Park JL, Kim M, et al. Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer. Biochem Biophys Res Commun. 2011;406(4):539–545. PMID: 21345334. doi:10.1016/j.bbrc.2011.02.082
- Fernandez AF, Assenov Y, Martin-Subero JI, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 2012;22(2):407–419. PMID: 21613409. doi:10.1101/gr.119867.110
- Zouridis H, Deng N, Ivanova T, et al. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med. 2012;4(156):156ra140. PMID: 23076357. doi:10.1126/scitranslmed.3004504
- Bandettini WP, Kellman P, Mancini C, et al. MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. J Cardiovasc Magn Reson. 2012;14:83. doi:10.1186/1532-429X-14-83
- Joo JK, Kim SH, Kim HG, et al. CpG methylation of transcription factor 4 in gastric carcinoma. Ann Surg Oncol. 2010;17(12):3344–3353. doi:10.1245/s10434-010-1131-z
- CHEN W, ZHENG R, BAADE PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338